MedTrace Logo

Exercise Interventions on Problematic Mobile Phone Use: a Multi-arm Randomized Controlled Trial

NCT05843591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-05-06

No results posted yet for this study

Summary

Problematic mobile phone use (PMPU) has been described as a growing public health issue. This randomized controlled trial aimed to determine if aerobic exercise or Tai Chi Chuan as compared to the wait-list control group decreased PMPU-related symptoms; and to analyze the composition of the intestinal flora in the three study groups to explore the correlation between PMPU scores and flora species. A consecutive sample of 90 college students with PMPU was randomized to the aerobic exercise group (AE group, n = 30), the Tai Chi Chuan group (TCC group, n = 30), or the wait-list control group (WLC group, n = 30). The primary outcome was addiction symptoms, i.e., the PMPU score as assessed by the Smartphone Addiction Scale-Short Version (SAS-SV). Secondary outcomes were the emotion-related symptoms (depression, anxiety, self-esteem and self-efficacy), and physical-related symptoms (sleep quality, physical-fatigue and mental-fatigue). Intervention effects were analyzed via generalized estimated equation analysis (GEE).

Conditions

  • Exercise Intervention
  • Tai Chi Chuan
  • Intestinal Flora
  • Randomized Clinical Trial

Interventions

BEHAVIORAL

aerobic exercise or Tai Chi Chuan interventions

8-week aerobic exercise (AE group), 8-week Tai Chi Chuan training (TCC group)

Sponsors & Collaborators

  • Anhui Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2022-06-03
Completion
2022-06-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05843591 on ClinicalTrials.gov